Kymera Therapeutics, Inc. (KYMR)
118.63
-0.42
(-0.35%)
USD |
NASDAQ |
Sep 02, 11:33
Kymera Therapeutics Net Income (TTM) : -299.60M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -299.60M |
| March 31, 2026 | -315.00M |
| December 31, 2025 | -311.35M |
| September 30, 2025 | -295.12M |
| June 30, 2025 | -275.43M |
| March 31, 2025 | -240.88M |
| December 31, 2024 | -223.86M |
| September 30, 2024 | -167.47M |
| June 30, 2024 | -157.85M |
| March 31, 2024 | -154.59M |
| December 31, 2023 | -146.96M |
| September 30, 2023 | -167.46M |
| June 30, 2023 | -157.59M |
| Date | Value |
|---|---|
| March 31, 2023 | -159.05M |
| December 31, 2022 | -154.81M |
| September 30, 2022 | -153.84M |
| June 30, 2022 | -139.42M |
| March 31, 2022 | -123.83M |
| December 31, 2021 | -100.22M |
| September 30, 2021 | -79.00M |
| June 30, 2021 | -58.41M |
| March 31, 2021 | -47.74M |
| December 31, 2020 | -45.59M |
| September 30, 2020 | -44.42M |
| June 30, 2020 | -47.85M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Anixa Biosciences, Inc. | -10.12M |